A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)

Clinical trial NCT06592339 · COMPLETED

Trial details

NCT number: NCT06592339
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2022-10-25
Primary completion: 2022-12-29
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.